Received Apr 21, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | IM / LA |
Slight fever; Muscle soreness/ sore muscles all over his body; Tenderness/ tenderness all over his body; Diarrhea; Ache; This non-serious case was reported by a consumer via call center representative and described the occurrence of fever in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included multiple sclerosis. On 11-APR-2026, the patient received the 1st dose of Shingrix (intramuscular, left arm). In APR-2026, 24 hrs after receiving Shingrix, the patient experienced fever (Verbatim: Slight fever), generalized muscle aches (Verbatim: Muscle soreness/ sore muscles all over his body), tenderness (Verbatim: Tenderness/ tenderness all over his body), diarrhea (Verbatim: Diarrhea) and pain (Verbatim: Ache). The outcome of the fever, generalized muscle aches, tenderness, diarrhea and pain were resolving. It was unknown if the reporter considered the fever, generalized muscle aches, tenderness, diarrhea and pain to be related to Shingrix. It was unknown if the company considered the fever, generalized muscle aches, tenderness, diarrhea and pain to be related to Shingrix. Additional Information: GSK Receipt Date: 14-APR-2026 The consumer stated that within 24 hours he experienced achy, slight fever, sore muscles throughout the body, generalized tenderness, and diarrhea. The consumer also stated that he was still recovering from the vaccine side effects but was slightly better on that day of reporting. The batch number was not provided upon follow up with the reporter.
Multiple sclerosis